VJHemOnc is committed to improving our service to you

EHA 2020 | Lymphoma cellular therapy update

VJHemOnc is committed to improving our service to you

Peter Borchmann

Peter Borchmann, MD , University Hospital Cologne, Cologne, Germany, gives an update on cellular therapy for the treatment of lymphoma. Specifically discussed is the UK-based ALEXANDER study (NCT03287817) of AUTO3, a bicistronic chimeric antigen receptor (CAR) targeting CD19 and CD22. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter